A Randomized Trial Comparing High Tibial Osteotomy Plus Non-Surgical Treatment and Non-Surgical Treatment Alone

December 4, 2023 updated by: Trevor Birmingham, Western University, Canada
The purpose of this study is to compare patients with knee osteoarthritis (OA) receiving optimized non-surgical treatment plus surgical realignment of the tibia, or optimized non-surgical treatment only. We hypothesize that outcomes assessed at 12 and 24 months follow-up will suggest favourable changes in patients undergoing surgical realignment when compared to patients receiving non-surgical treatment only.

Study Overview

Detailed Description

This two groups, parallel design randomized controlled trial will compare patients with medial compartment knee OA and varus alignment receiving optimized non-surgical treatment plus High Tibial Osteotomy (HTO) to similar patients receiving optimized non-surgical treatment only. All participants will receive non-surgical treatment that will be individualized to the patient and include medications, physiotherapy and nutritional seminars. The non-surgical treatment will include supervised physiotherapy and nutritional seminars once per week for 12 weeks, will be accompanied and followed by a home program, and follow-up appointments for potential modification every three months for the duration of the study. Participants randomized to surgery will also undergo medial opening wedge HTO after 12 weeks of optimized non-surgical treatment. Both groups will follow the same schedule of clinic visits throughout the 24 month follow-up period. MRI-derived measures of articular cartilage morphology, biological markers of articular cartilage degradation and synthesis, gait biomechanics and patient-reported outcomes will be assessed at baseline, 12 and 24 months follow-up.

Study Type

Interventional

Enrollment (Actual)

71

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • London, Ontario, Canada, N6A 3K7
        • Fowler Kennedy Sport Medicine Clinic, Western University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Is the subject either:

    1. 25-55 years old?
    2. Older than 55 but still active (ex. physical labour, regular recreational activities)?
  2. Does this subject present with varus alignment? (Based on hip to ankle x-rays).
  3. Does this subject have clinical Knee OA? (MAA <-2° on full limb standing AP) according to the Altman classification primarily involving the medial compartment of the knee?
  4. Patient is a good candidate for high tibial osteotomy and will be receiving a PEEK plate, or if receiving an alternate plate, agrees to have the plate removed prior to 1 year postoperative.

Exclusion Criteria:

  1. Has this subject had a previous HTO or joint replacement in either limb?
  2. Is this subject likely to undergo bilateral HTO within the 2 year follow up period?
  3. Does this subject have an unstable knee or ligament?
  4. Does this subject have inflammatory or infectious arthritis of the knee?
  5. Radiographic disease too advanced for HTO (ie. diffuse lateral compartment, patellofemoral joint OA and/or severe enough disease to suggest that joint replacement is the better surgical option) and/or Kellgren and Lawrence grade 4.
  6. The subject's disease is not advanced enough (symptomatically or radiographically) to warrant HTO.
  7. Does this subject have a major medical illness with life expectancy <2 years or with an unacceptably high operative risk?
  8. Does this subject have a major neurological deficit that would affect gait?
  9. Is this subject possibly pregnant or planning pregnancy?
  10. Is this subject unable to read English?
  11. Does this subject have a psychiatric illness that limits informed consent?
  12. Is the subject unlikely to comply with study protocol?

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Non-Surgical Treatment plus HTO
The optimized non-surgical treatment program consists of medications, physiotherapy and nutritional seminars. The 12-week program will include an assessment by a primary care physician, physiotherapist and orthopaedic surgeon, one supervised physiotherapy session per week, one body recomposition session per week, and a home program. After the 12-week program is completed, patients randomized to this group will undergo a medial opening wedge high tibial osteotomy (HTO). They will continue with their home program and will be followed up for 2 years after baseline.
A lower limb realignment surgery to redistribute load away from the most affected portion of the knee.
A 12-week optimized non-surgical treatment program consisting of medication, physiotherapy and nutritional seminars.
Active Comparator: Non-Surgical Treatment
The optimized non-surgical treatment program consists of medications, physiotherapy and nutritional seminars. The 12-week program will include an assessment by a primary care physician, physiotherapist and orthopaedic surgeon, one supervised physiotherapy session per week, one body recomposition session per week, and a home program. After the 12-week program is completed, patients randomized to this group will continue with their home program and will be followed up for 2 years after baseline.
A 12-week optimized non-surgical treatment program consisting of medication, physiotherapy and nutritional seminars.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MRI articular cartilage morphology
Time Frame: Change from baseline to 24 months post operative
3 Tesla MRI measure of medial tibiofemoral articular cartilage thickness
Change from baseline to 24 months post operative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Time Frame: Change from baseline to 24 months post operative
Patient-reported outcome measure. 5 subdomains: pain, symptoms, activities of daily living, sport and recreation, quality of life
Change from baseline to 24 months post operative
Western Ontario Meniscal Evaluation Tool (WOMET)
Time Frame: Change from baseline to 24 months post operative
Patient-reported outcome measure. Assesses health-related quality of life (HRQoL) in patients with meniscal tears. 3 dimensions: physical symptoms, sports/recreation/work/lifestyle, emotions
Change from baseline to 24 months post operative
Biological Markers of Disease Progression
Time Frame: Baseline, 12 and 24 months post operative
Synovial fluid, serum and urine biological markers
Baseline, 12 and 24 months post operative
Numeric Rating Scale for Pain
Time Frame: Baseline, 12 and 24 months post operative
Patient-reported outcome measure. Assesses patient's pain. 0 (no pain) - 10 (worst possible pain)
Baseline, 12 and 24 months post operative
Gait Biomechanics
Time Frame: Baseline, 12 and 24 months post operative
Knee frontal, sagittal and transverse plane kinematics and kinetics tested during level walking in a motion analysis laboratory. The measure of most interest is the peak external knee adduction moment during stance phase of walking.
Baseline, 12 and 24 months post operative
Isometric Strength Testing
Time Frame: Baseline, 12 and 24 months post operative
Isometric quadriceps and hamstrings strength tested using an isokinetic dynamometer.
Baseline, 12 and 24 months post operative
Intermittent and Constant Osteoarthritis Pain Index (ICOAP)
Time Frame: Change from baseline to 24 months post operative
Patient-reported outcome measure. Assesses pain in individuals with hip or knee osteoarthritis taking into account both constant and intermittent pain. 3 domains: intermittent pain, constant pain, total pain
Change from baseline to 24 months post operative
Short-Form 12 (SF12)
Time Frame: Change from baseline to 24 months post operative
Patient-reported outcome measure. Self-reported outcome measure assessing the impact of health on an individual's everyday life
Change from baseline to 24 months post operative
Western Ontario and McMaster Universities Arthritis Index (WOMAC)
Time Frame: Change from baseline to 24 months post operative
Patient-reported outcome measure. 3 sub domains: pain, symptoms, function
Change from baseline to 24 months post operative

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cost-effectiveness questionnaires
Time Frame: Baseline and every 3 months from baseline up to 24 months post operative
Collection of accumulated direct and indirect costs related to the intervention incurred over the study period as reported by the patient.
Baseline and every 3 months from baseline up to 24 months post operative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Trevor B Birmingham, PT, PhD, Western University
  • Principal Investigator: J R Giffin, MD, Western University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 5, 2014

Primary Completion (Actual)

April 18, 2023

Study Completion (Estimated)

April 1, 2024

Study Registration Dates

First Submitted

December 2, 2013

First Submitted That Met QC Criteria

December 2, 2013

First Posted (Estimated)

December 6, 2013

Study Record Updates

Last Update Posted (Actual)

December 5, 2023

Last Update Submitted That Met QC Criteria

December 4, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on Medial Opening Wedge High Tibial Osteotomy (HTO)

3
Subscribe